Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country.
Traditional Chinese herbal Medicine (TCHM) has been gaining interest and acceptance world wide. TCHM provides on the one side promising perspective of scientific interest and on the other side possible health risks if TCHM drugs are not controlled with respect to quality standards or if practitioners for TCHM are not well trained. This paper outlines an introduction to the scientific aspects and potential risks of TCHM therapy followed by a brief, exploratory overview of the current status of TCHM regulations in certain Western countries like the USA, United Kingdom, Germany, Australia and in China as the Eastern origin country of TCHM. Legal foundations to establish quality and safety standards for TCHM crude drugs and ready-made formulas exist in some countries on a local basis but in practice are poorly enforced, where this products have no drug status. In addition practitioners treating patients with TCHM should be well versed in the pharmacology, side effects, and interactions of these substances with Western medicines and should be certified on a regular basis.
Dobos
G J
GJ
Alfried Krupp von Bohlen and Halbach-Foundation, University Duisburg-Essen at the Kliniken Essen-Mitte, Am Deimelsberg 34 A, 45276 Essen, Germany. gustav.dobos@uni-essen.de
Tan
L
L
Cohen
M H
MH
McIntyre
M
M
Bauer
R
R
Li
X
X
Bensoussan
A
A
D003257:Consumer Product Safety; D019049:Developed Countries; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D004365:Drugs, Chinese Herbal / Q000009:adverse effects / Q000191:economics / Q000592:standards*; D006801:Humans; D011786:Quality Control
D004365:Drugs, Chinese Herbal